Influenza Encephalopathy: What Is Encephalopathy?

[1]  H. Tsukahara,et al.  Epidemiology of Pediatric Acute Encephalitis/Encephalopathy in Japan. , 2018, Acta medica Okayama.

[2]  T. Uyeki,et al.  Characteristics and Outcomes of Influenza-Associated Encephalopathy Cases Among Children and Adults in Japan, 2010–2015 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Takanashi,et al.  Activated microglia in acute encephalopathy with biphasic seizures and late reduced diffusion , 2016, Journal of the Neurological Sciences.

[4]  H. Tamai,et al.  Targeted temperature management for acute encephalopathy in a Japanese secondary emergency medical care hospital , 2016, Brain and Development.

[5]  A. Barkovich,et al.  Disrupted glutamate-glutamine cycle in acute encephalopathy with biphasic seizures and late reduced diffusion , 2015, Neuroradiology.

[6]  S. Saitoh,et al.  Seizure characteristics of epilepsy in childhood after acute encephalopathy with biphasic seizures and late reduced diffusion , 2015, Epilepsia.

[7]  G. Yamanaka,et al.  Brain-Derived Neurotrophic Factor and Interleukin-6 Levels in the Serum and Cerebrospinal Fluid of Children with Viral Infection-Induced Encephalopathy , 2014, Neurochemical Research.

[8]  S. Takeshita,et al.  Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  T. Morishima,et al.  High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy , 2014, Brain and Development.

[10]  T. Solomon,et al.  Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Takanashi,et al.  ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus , 2013, Neurology.

[12]  Yoshiaki Gu,et al.  National Surveillance of Influenza-Associated Encephalopathy in Japan over Six Years, before and during the 2009–2010 Influenza Pandemic , 2013, PloS one.

[13]  Y. Zurynski,et al.  Neurologic complications of influenza A(H1N1)pdm09 , 2012, Neurology.

[14]  T. Morishima,et al.  National survey of pandemic influenza A (H1N1) 2009‐associated encephalopathy in Japanese children , 2012, Journal of medical virology.

[15]  J. Takanashi,et al.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes , 2012, Brain and Development.

[16]  M. Mizuguchi,et al.  Mutations of the SCN1A gene in acute encephalopathy , 2012, Epilepsia.

[17]  A. Brooks-Kayal,et al.  Pediatric neurological complications of 2009 pandemic influenza A (H1N1). , 2011, Archives of neurology.

[18]  A. Okumura,et al.  Amplitude-integrated electroencephalography in patients with acute encephalopathy with refractory, repetitive partial seizures , 2011, Brain and Development.

[19]  M. Yashiro,et al.  Increase of tumor necrosis factor‐α in the blood induces early activation of matrix metalloproteinase‐9 in the brain , 2010, Microbiology and immunology.

[20]  O. Iwata,et al.  Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling , 2010, Archives of Disease in Childhood.

[21]  T. Fukaya,et al.  Reversible splenial lesion associated with novel influenza A (H1N1) viral infection. , 2010, Pediatric neurology.

[22]  M. Adams,et al.  Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. , 2009, American journal of human genetics.

[23]  J. Purevsuren,et al.  Urinary organic metabolite screening of children with influenza-associated encephalopathy for inborn errors of metabolism using GC/MS , 2008, Brain and Development.

[24]  N. Okabe,et al.  Prognostic Factors in Influenza-associated Encephalopathy , 2008, The Pediatric infectious disease journal.

[25]  T. Morishima,et al.  MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITORS OF METALLOPROTEINASES 1 IN INFLUENZA-ASSOCIATED ENCEPHALOPATHY , 2007, The Pediatric infectious disease journal.

[26]  M. Mizuguchi,et al.  Acute encephalopathy associated with influenza and other viral infections , 2007, Acta neurologica Scandinavica. Supplementum.

[27]  T. Muta,et al.  A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. , 2006, Clinical immunology.

[28]  H. Kido,et al.  Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza‐associated encephalopathy , 2005, FEBS letters.

[29]  T. Morishima,et al.  NOx (nitrite/nitrate) in cerebral spinal fluids obtained from patients with influenza-associated encephalopathy. , 2003, Neuropediatrics.

[30]  H. Ozawa,et al.  Cerebrospinal Fluid and Serum Levels of Cytokines and Soluble Tumor Necrosis Factor Receptor in Influenza Virus-associated Encephalopathy , 2003, Scandinavian journal of infectious diseases.

[31]  M. Tashiro,et al.  Encephalitis and encephalopathy associated with an influenza epidemic in Japan. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.